Creutzfeldt-Jakob Disease

Creutzfeldt-Jakob Disease is a rapidly progressive fatal neurodegenerative disease caused by prion accumulation causing spongiform brain appearance and is characterised by T2 changes in the basal ganglia, thalamus, and cortex.

Description

Creutzfeldt-Jakob Disease (CJD) is a rare, fatal neurodegenerative disorder caused by abnormal prion proteins. It leads to rapid brain damage and a characteristic spongiform appearance of the brain tissue. Patients classically present with rapid cognitive decline, ataxia, and myoclonus.

Pathogenesis

CJD is caused by the misfolding of a normal cellular protein (prion protein) into a pathogenic form which accumulates in and around neurons, leading to brain cell death. The prions can be created endogenously from misfolded normally host-encoded protein or can be infectious, or less commonly be acquired through contaminated food or medical procedures.

Subtypes

  • Sporadic CJD (sCJD): Most common form (90%), occurring without known risk factors.
  • Familial CJD: Second most common (10%). Caused by an inherited genetic mutation in the PRNP gene.
  • Variant CJD (vCJD): Rare. Linked to consumption of beef infected with Bovine Spongiform Encephalopathy (Mad Cow Disease).
  • Iatrogenic CJD: Resulting from medical procedures using contaminated instruments or tissues.

Epidemiology, Risk Factors & Associations

  • Affects about 1-1.5 per million people worldwide annually.
  • Most cases are sporadic with no identified risk factors.
  • Familial CJD is associated with mutations in the PRNP gene.

Clinical Features

  • Rapidly progressive dementia.
  • Neurological symptoms including ataxia, myoclonus, and visual disturbances.
  • Behavioral and personality changes.
  • Muscle stiffness and weakness.

Complications

  • Severe neurological impairment leading to bedridden state.
  • Myoclonus and other involuntary movements.
  • Mutism and loss of voluntary movement.
  • Death, typically within a year of symptom onset.

Pathological Features

Histopathology
  • Macroscopic: Brain atrophy in advanced stages.
  • Microscopic: Spongiform changes, neuronal loss, and gliosis with prion protein deposits.

Radiological Features

General Features
  • High signal abnormalities in the cortical and basal ganglia regions.
MRI
  • T2/FLAIR: Hyperintense signal in the basal ganglia, thalamus and cortical ribbon (especially insula).
    • Cortical ribboning – is seen in sCJD.
    • Pulvinar sign – Symmetric T2 hyperintensity in the pulvinar nuclei/posterior region of thalmus, seen in vCJD
    • Hockey-stick sign – Combination of pulvinar sign and increased signal in the dorsomedial thalamus
  • T1: Usually unremarkable. No involvement of white matter.
  • DWI/ADC: Restricted diffusion in affected cortical areas. DWI hyperintensity reduces over time.
  • T1 Gad+: No significant enhancement typically.
CT
  • Often normal in early disease; may show generalised brain atrophy in later stages.
PET FDG
  • May show decreased cerebral metabolism in affected areas.

Grading and Staging

  • Not formally graded or staged; progression is typically rapid and uniform.

Diagnosis

  • Based on clinical presentation, EEG, MRI findings, and CSF analysis for 14-3-3 protein.
  • Definitive diagnosis requires brain biopsy or post-mortem examination.

Differential Diagnosis

Clinical-based
  • Alzheimer’s disease: More gradual cognitive decline and different MRI findings.
  • Vascular dementia: Stepwise deterioration with history of strokes.
  • Other rapidly progressive dementias like Lewy body dementia.
Imaging-based

More Common

  • Acute Cerebral Ischemia-Infarction: Diffusion restriction in basal ganglia & thalamus due to occlusion of small perforators arising from circle of Willis, often unilateral. Bilateral paramedian thalamic &/or midbrain infarcts. Occlusion of artery of Percheron or tip of basilar artery
  • Deep Venous Thrombosis: Thrombotic occlusion of internal cerebral veins, vein of Galen, straight sinus can cause T2/FLAIR hyperintense swelling of thalami & basal ganglia with diffusion restriction (seen early)

Less Common

  • Drug abuse: Cocaine, amphetamines, MDMA (ecstasy), heroin, & opiates can cause restricted diffusion in the basal ganglia. Globus pallidi & occipital cortex are susceptible to MDMA-induced ischaemia.
  • Osmotic Demyelination Syndrome: Occurs in alcoholic, hyponatremic patients with rapid correction of serum sodium. Typically affects pons. Extrapontine manifestations include T2/FLAIR hyperintensity in globus pallidus, putamen, thalamus and may show restricted diffusion (early).
  • Status Epilepticus: Seizures persisting for more than 5 minutes. DWI restriction (acute-subacute phases) and T2 hyperintensity can be seen in gray matter, subcortical white matter and often the pulvinar nucleus of thalamus.

Management

  • No cure; management is supportive and palliative.
  • Symptomatic treatment for myoclonus, seizures, and psychiatric symptoms.
  • Multidisciplinary care including neurology, psychiatry, and palliative care teams.
Updated on 9 April 2024

Was this article helpful?

Related Articles